Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Pharmapreneur - Defining a Framework for Entrepreneurship in Pharmacy Education.

Mattingly TJ 2nd, Abdelwadoud M, Mullins CD, Eddington ND.

Am J Pharm Educ. 2019 Dec;83(10):7548. doi: 10.5688/ajpe7548.

2.

A Systematic Review of Entrepreneurship in Pharmacy Practice and Education.

Mattingly TJ 2nd, Mullins CD, Melendez DR, Boyden K, Eddington ND.

Am J Pharm Educ. 2019 Apr;83(3):7233. doi: 10.5688/ajpe7233. Review.

3.

Trends in the Pharmacist Workforce and Pharmacy Education.

Lebovitz L, Eddington ND.

Am J Pharm Educ. 2019 Feb;83(1):7051. doi: 10.5688/ajpe7051.

4.

ASHP Foundation Pharmacy Forecast 2019: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems.

Vermeulen LC, Eddington ND, Gourdine MA, Jorgenson J, Kvancz DA, Nesbit SA, Bicket MC, Zellmer WA, Hine A, Belford S, Peters SG, Hoffman JM, Schwab WE, Knoer S, Cosgrove DT, Kent SS, Clark JS.

Am J Health Syst Pharm. 2019 Jan 16;76(2):71-100. doi: 10.2146/sp180010. No abstract available.

PMID:
30373935
5.

Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.

Merchan LM, Hassan HE, Terrin ML, Waites KB, Kaufman DA, Ambalavanan N, Donohue P, Dulkerian SJ, Schelonka R, Magder LS, Shukla S, Eddington ND, Viscardi RM.

Antimicrob Agents Chemother. 2015 Jan;59(1):570-8. doi: 10.1128/AAC.03951-14. Epub 2014 Nov 10.

6.

Opioids and efflux transporters. Part 4: influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues.

Metcalf MD, Rosicky AD, Hassan HE, Eddington ND, Coop A, Cunningham CW, Mercer SL.

Bioorg Med Chem Lett. 2014 Aug 1;24(15):3592-5. doi: 10.1016/j.bmcl.2014.05.033. Epub 2014 May 22.

7.

AACP Council of Deans report, July 2013.

DiPiro JT, Crismon ML, Evans RL Jr, Meyer SM, Eddington ND, Lau V.

Am J Pharm Educ. 2013 Nov 12;77(9):S14. doi: 10.5688/ajpe779S14. No abstract available.

8.

Induction of xenobiotic receptors, transporters, and drug metabolizing enzymes by oxycodone.

Hassan HE, Myers AL, Lee IJ, Mason CW, Wang D, Sinz MW, Wang H, Eddington ND.

Drug Metab Dispos. 2013 May;41(5):1060-9. doi: 10.1124/dmd.112.050401. Epub 2013 Feb 25.

PMID:
23439660
9.

Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.

Viscardi RM, Othman AA, Hassan HE, Eddington ND, Abebe E, Terrin ML, Kaufman DA, Waites KB.

Antimicrob Agents Chemother. 2013 May;57(5):2127-33. doi: 10.1128/AAC.02183-12. Epub 2013 Feb 25.

10.

The impact of AT1002 on the delivery of ritonavir in the presence of bioadhesive polymer, carrageenan.

Song KH, Eddington ND.

Arch Pharm Res. 2012 May;35(5):937-43. doi: 10.1007/s12272-012-0520-1. Epub 2012 May 29.

PMID:
22644862
11.

Enaminones 12. An explanation of anticonvulsant activity and toxicity per Linus Pauling's clathrate hypothesis.

Jackson PL, Hanson CD, Farrell AK, Butcher RJ, Stables JP, Eddington ND, Scott KR.

Eur J Med Chem. 2012 May;51:42-51. doi: 10.1016/j.ejmech.2012.02.003. Epub 2012 Feb 9.

PMID:
22417639
12.

The influence of stabilizer and bioadhesive polymer on the permeation-enhancing effect of AT1002 in the nasal delivery of a paracellular marker.

Song KH, Eddington ND.

Arch Pharm Res. 2012 Feb;35(2):359-66. doi: 10.1007/s12272-012-0217-5. Epub 2012 Feb 28.

PMID:
22370791
13.

The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.

Song KH, Eddington ND.

J Pharm Pharmacol. 2012 Jan;64(1):30-9. doi: 10.1111/j.2042-7158.2011.01381.x. Epub 2011 Nov 21.

PMID:
22150669
14.

Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver.

Upreti VV, Moon KH, Yu LR, Lee IJ, Eddington ND, Ye X, Veenstra TD, Song BJ.

Proteomics. 2011 Jan;11(2):202-11. doi: 10.1002/pmic.201000203. Epub 2010 Dec 15.

15.

Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.

Hassan HE, Othman AA, Eddington ND, Duffy L, Xiao L, Waites KB, Kaufman DA, Fairchild KD, Terrin ML, Viscardi RM.

J Clin Pharmacol. 2011 Sep;51(9):1264-75. doi: 10.1177/0091270010382021. Epub 2010 Nov 23.

16.

Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells.

Li L, Hassan HE, Tolson AH, Ferguson SS, Eddington ND, Wang H.

J Pharmacol Exp Ther. 2010 Dec;335(3):562-71. doi: 10.1124/jpet.110.173187. Epub 2010 Sep 9.

18.

Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Song BJ, Moon KH, Upreti VV, Eddington ND, Lee IJ.

Curr Pharm Biotechnol. 2010 Aug;11(5):434-43. Review.

19.

Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse.

Mason CW, Hassan HE, Kim KP, Cao J, Eddington ND, Newman AH, Voulalas PJ.

J Pharmacol Exp Ther. 2010 Jun;333(3):854-64. doi: 10.1124/jpet.109.165084. Epub 2010 Mar 12.

20.

The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.

Fisher SJ, Swaan PW, Eddington ND.

J Pharmacol Exp Ther. 2010 Jan;332(1):326-33. doi: 10.1124/jpet.109.158642. Epub 2009 Oct 9.

PMID:
19820208
21.

Estradiol and progesterone-mediated regulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and placental cells (JAR).

Coles LD, Lee IJ, Voulalas PJ, Eddington ND.

Mol Pharm. 2009 Nov-Dec;6(6):1816-25. doi: 10.1021/mp900077q.

PMID:
19813763
22.

Regulation of gene expression in brain tissues of rats repeatedly treated by the highly abused opioid agonist, oxycodone: microarray profiling and gene mapping analysis.

Hassan HE, Myers AL, Lee IJ, Chen H, Coop A, Eddington ND.

Drug Metab Dispos. 2010 Jan;38(1):157-67. doi: 10.1124/dmd.109.029199.

23.

Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor.

Tolson AH, Li H, Eddington ND, Wang H.

Drug Metab Dispos. 2009 Sep;37(9):1887-94. doi: 10.1124/dmd.109.027854. Epub 2009 Jun 11.

24.

Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions.

Hassan HE, Mercer SL, Cunningham CW, Coop A, Eddington ND.

Int J Pharm. 2009 Jun 22;375(1-2):48-54. doi: 10.1016/j.ijpharm.2009.03.037. Epub 2009 Apr 5.

25.

Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen.

Teksin ZS, Lee IJ, Nemieboka NN, Othman AA, Upreti VV, Hassan HE, Syed SS, Prisinzano TE, Eddington ND.

Eur J Pharm Biopharm. 2009 Jun;72(2):471-7. doi: 10.1016/j.ejpb.2009.01.002.

26.

Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy").

Upreti VV, Eddington ND, Moon KH, Song BJ, Lee IJ.

Toxicol Lett. 2009 Jul 24;188(2):167-72. doi: 10.1016/j.toxlet.2009.03.023. Epub 2009 Apr 5.

28.

Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice.

Coles LD, Lee IJ, Hassan HE, Eddington ND.

J Pharm Sci. 2009 Aug;98(8):2832-46. doi: 10.1002/jps.21644.

PMID:
19116954
29.

Phospholipid-induced in vivo particle migration to enhance pulmonary deposition.

Ganguly S, Moolchandani V, Roche JA, Shapiro PS, Somaraju S, Eddington ND, Dalby RN.

J Aerosol Med Pulm Drug Deliv. 2008 Dec;21(4):343-50. doi: 10.1089/jamp.2007.0675.

PMID:
18823258
30.

Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver.

Moon KH, Upreti VV, Yu LR, Lee IJ, Ye X, Eddington ND, Veenstra TD, Song BJ.

Proteomics. 2008 Sep;8(18):3906-18. doi: 10.1002/pmic.200800215.

31.

Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin.

Myers AL, Upreti VV, Khurana M, Eddington ND.

J Clin Pharmacol. 2008 Oct;48(10):1158-70. doi: 10.1177/0091270008323751. Epub 2008 Aug 29.

PMID:
18757783
32.

Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs.

Mercer SL, Cunningham CW, Eddington ND, Coop A.

Bioorg Med Chem Lett. 2008 Jun 15;18(12):3638-40. doi: 10.1016/j.bmcl.2008.04.046. Epub 2008 Apr 25.

34.

Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs.

Cunningham CW, Mercer SL, Hassan HE, Traynor JR, Eddington ND, Coop A.

J Med Chem. 2008 Apr 10;51(7):2316-20. doi: 10.1021/jm701457j. Epub 2008 Feb 27.

35.

Enhanced nasal absorption of hydrophilic markers after dosing with AT1002, a tight junction modulator.

Song KH, Fasano A, Eddington ND.

Eur J Pharm Biopharm. 2008 May;69(1):231-7. Epub 2007 Nov 26.

PMID:
18039562
36.

Evaluation of the effect of ethanol's toxic metabolite acetaldehyde on the gastrointestinal oligopeptide transporter, PEPT1: in vitro and in vivo studies.

Fisher SJ, Lee IJ, Swaan PW, Eddington ND.

Alcohol Clin Exp Res. 2008 Jan;32(1):162-70. Epub 2007 Nov 20.

PMID:
18028524
37.

Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.

Song KH, Fasano A, Eddington ND.

Int J Pharm. 2008 Mar 3;351(1-2):8-14. Epub 2007 Sep 15.

PMID:
17954018
39.
40.

Enaminones: Exploring additional therapeutic activities.

Edafiogho IO, Kombian SB, Ananthalakshmi KV, Salama NN, Eddington ND, Wilson TL, Alexander MS, Jackson PL, Hanson CD, Scott KR.

J Pharm Sci. 2007 Oct;96(10):2509-31. Review.

PMID:
17621683
42.
44.

Opioids and efflux transporters. Part 1: P-glycoprotein substrate activity of N-substituted analogs of meperidine.

Mercer SL, Hassan HE, Cunningham CW, Eddington ND, Coop A.

Bioorg Med Chem Lett. 2007 Mar 1;17(5):1160-2. Epub 2006 Dec 21.

45.

Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling.

Kitchens KM, Kolhatkar RB, Swaan PW, Eddington ND, Ghandehari H.

Pharm Res. 2006 Dec;23(12):2818-26. Epub 2006 Nov 9.

PMID:
17094034
46.

Return of chloroquine antimalarial efficacy in Malawi.

Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV.

N Engl J Med. 2006 Nov 9;355(19):1959-66.

47.
48.

QSAR of the anticonvulsant enaminones; molecular modeling aspects and other assessments.

Wilson TL, Jackson PL, Hanson CD, Xue Z, Eddington ND, Scott KR.

Med Chem. 2005 Jul;1(4):371-81.

PMID:
16789894
50.

Tight junction modulation and its relationship to drug delivery.

Salama NN, Eddington ND, Fasano A.

Adv Drug Deliv Rev. 2006 Apr 20;58(1):15-28. Epub 2006 Mar 6. Review.

PMID:
16517003

Supplemental Content

Loading ...
Support Center